Search

everythinglearnresearchcommunity

for

Search:↓

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

A woman with anorexia nervosa improved after treatment for pellagra, reminding doctors to check for this deficiency in patients with eating disorders.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.